Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monomeric CXCL121 peptide and methods of treating autoimmune diseases

Monomeric CXCL121 peptide and methods of treating autoimmune diseases

US Patent 10537613 · Granted Jan 21, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered CCL20 locked dimer polypeptide2023
Engineered CCL20 locked dimer polypeptide2023
Methods of treating inflammation with monomeric CXCL12 peptide2022
Methods of treating inflammation with monomeric CXCL12 peptide2022
Methods of treating inflammation with monomeric CXCL12 peptide2022
Methods of treating inflammation with monomeric CXCL12 peptide2022
Engineered CCL20 locked dimer polypeptide2020
Engineered CCL20 locked dimer polypeptide2020
Monomeric CXCL121 peptide and methods of use thereof2018
Monomeric CXCL121 peptide and methods of use thereof2018
Monomeric CXCL121 peptide and methods of use thereof2018
Monomeric CXCL121 peptide and methods of use thereof2018